How to pay the least
Ask for the cash price
Abrilada
Abrilada is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
- Ask your pharmacy for Abrilada’s cash price, and one or two other pharmacies too.
Compare every option
Details for each option
Brand nameTrumpRx.gov price
TrumpRx.gov, the federal government’s drug price site, lists Abrilada at a price its maker agreed to, for people paying without insurance.
- TrumpRx.gov $207.60Prefilled Pen, 40/0.8 mgGet the free coupon on TrumpRx’s page and show it at the pharmacy.
From TrumpRx.gov, read October 28, 2026. Its page opens on this price; other strengths and amounts are priced there too. With insurance, check your co-pay first: it may be lower.
Authorized genericNot sold
There isn’t one. An authorized generic is Abrilada itself, from the same company, sold without the brand name, and usually for less. For now Abrilada is the only choice; ask the pharmacy for its cash price, or your plan what it charges.
Regular genericNot sold
Abrilada is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Abrilada’s cash price, or your plan what it charges.
What it’s used for
- Rheumatoid arthritis and juvenile arthritis (JIA)
- Plaque psoriasis
- Crohn’s disease
- Ulcerative colitis
- Psoriatic arthritis
- Ankylosing spondylitis (arthritis of the spine)
- Hidradenitis suppurativa (painful lumps under the skin)
- Non-infectious uveitis (inflammation in the middle or back of the eye)
What the FDA label says
ABRILADA is a tumor necrosis factor (TNF) blocker indicated for:
- Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
- Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
- Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
- Reducing signs and symptoms in adult patients with active ankylosing spondylitis.
- Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
- Treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
- Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
- Treatment of moderate to severe hidradenitis suppurativa in adult patients.
- Treatment of non-infectious intermediate, posterior, and panuveitis in adult patients.
Source: the FDA label for Abrilada (Pfizer Laboratories Div Pfizer Inc), May 6, 2026. Full label on DailyMed
Good to know
- We didn’t find a savings card from Abrilada’s maker.
- Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/abrilada/